000078 ST海王生物
按盤價 
1.270 -0.010 (-0.781%)
1.270 -0.010 (-0.781%) | 2026/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 16,171,269 | -24.83% | 26,667,709 | 30,317,288 | 36,418,770 | 37,834,859 | |
| 減：營業總成本 | 16,306,324 | -24.02% | 26,741,852 | 30,630,058 | 36,503,984 | 37,782,459 | |
| 其中:營業成本 | 14,628,713 | -25.10% | 24,209,623 | 27,444,707 | 32,865,445 | 34,045,035 | |
| 財務費用 | 338,455 | -24.77% | 613,669 | 806,282 | 943,621 | 905,212 | |
| 資產減值損失 | (9,583) | -185.40% | (126,427) | (518,749) | (962,355) | (550,406) | |
| 公允價值變動收益 | 2,569 | 1,717.07% | 11,995 | 6,384 | 17,752 | 56,847 | |
| 投資收益 | (52,848) | -157.67% | 8,921 | 11,147 | (45,418) | (143,505) | |
| 其中：對聯營企業和合營企業的投資收益 | (1,203) | -435.72% | 5,869 | 4,318 | (26,996) | (106,917) | |
| 營業利潤 | (315,315) | -290.49% | (504,929) | (1,062,938) | (1,468,030) | (854,588) | |
| 利潤總額 | (316,062) | -288.24% | (499,300) | (1,081,694) | (1,458,474) | (853,160) | |
| 減：所得稅費用 | 51,555 | -48.27% | 53,256 | 85,617 | 260,559 | 138,290 | |
| 淨利潤 | (367,616) | -638.71% | (552,556) | (1,167,311) | (1,719,033) | (991,450) | |
| 減：非控股權益 | 3,005 | -92.94% | 10,504 | 26,104 | (29,088) | 35,519 | |
| 股東淨利潤 | (370,622) | -1,541.94% | (563,060) | (1,193,415) | (1,689,945) | (1,026,969) | |
市場價值指標 | |||||||
| 每股收益 (元) * | -0.141 | -1,537.76% | -0.214 | -0.454 | -0.642 | -0.391 | |
| 每股派息 (元) * | -- | -- | -- | -- | -- | -- | |
| 每股淨資產 (元) * | 0.325 | -53.00% | 0.466 | 0.682 | 1.092 | 1.705 | |
| 審計意見 # | -- | 保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 13/11/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
